Local and systemic effects of a silver nitrate coated indwelling pleural catheter in an animal model of pleurodesis

被引:6
|
作者
Tremblay, Alain [1 ]
Kearney, Christine T. [2 ]
Hanks, Chris [3 ]
Hanks, Jennifer Hughes [3 ]
White, David S. [3 ]
Pereira, Marcia E. [4 ]
Zook, Craig E. [4 ]
Sargis, Karen [2 ]
Zhang, Luke [3 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[2] Becton Dickinson & Co Inc, Vernon hills, IL USA
[3] Sinclair Res Ctr LLC, Auxvasse, MO USA
[4] Histosci Res Labs Inc, Mt Jackson, VA USA
关键词
cancer; pleurodesis; pleural effusion; silver nitrate; SPONTANEOUS PNEUMOTHORAX; MANAGEMENT; EFFICACY; SAFETY;
D O I
10.1080/01902148.2017.1384865
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose/Aim of the study: This study assessed the safety and potential toxicity of a silver nitrate coated indwelling pleural catheter (SNCIPC) designed to create pleurodesis in a large animal model. Materials andMethods: Sixteen animals underwent insertion of either a SNCIPC or an uncoated silicone catheter. Half of the animals were sacrificed at day 7 and the others at day 30. Animal weight and assessment ofwell-being, pleural fluid and blood collectionwere performed at regular intervals. Pleurodesis was assessed at necropsy and histopathological examination of organs performed. Results: No mortality or significant clinical findingswere observed throughout the experiment. SNCIPC treated animals had increased pleural fluid drainage overall (p < 0.001) and specifically on days 1-4. No differences in hemoglobin, white blood cell count or neutrophil countswere detected between groups. No treatment related histological findings were observed in any of the evaluated tissues outside of the treated area. Serum silver levels in SNCIPC catheter treated animals peaked on Day 4 (0.185 mu g/mL, 30 day group) then gradually decreased for the remainder of the study period. The highest tissue silver concentrationswere noted in the SNCIPC groups in tissues close to the treatment site in addition to the liver (59.8ug/g +/-8.6 and 73.3ug/g +/-25). Pleurodesis scores were significantly higher in SNCIPC treated animals for both the 7 day (median 6.5 vs. 1.0, p = 0.029) and 30 day cohorts (median 7.0 vs. 1.5, p= 0.029). Conclusions: SNCIPC arewell tolerated and not associated with any significant signs of toxicity. Silver levels were elevated in local tissues, serum and liver but without evidence of pathological impact. Effective pleurodesis was present by day 7 and more established by day 30. Clinical studies to investigate the safety and efficacy of this device in patients with malignant pleural effusions appear warranted.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 50 条
  • [1] Modified indwelling pleural catheter versus silver nitrate pleurodesis for the management of malignant pleural effusion
    Abdelghany, Mohammed F.
    Essmat, Khaled
    El-Karn, Atef Farouk
    Youssif, Sahar Farghly
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2022, 71 (02): : 248 - 254
  • [2] Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions
    Iyer, Narayan P.
    Reddy, Chakravarthy B.
    Wahidi, Momen M.
    Lewis, Sandra Z.
    Diekemper, Rebecca L.
    Feller-Kopman, David
    Gould, Michael K.
    Balekian, Alex A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (01) : 124 - 131
  • [3] INDWELLING PLEURAL CATHETER IODOPOVIDONE PLEURODESIS FOR MALIGNANT PLEURAL EFFUSIONS
    Ho, Patrick
    Berg, Benjamin
    Langston, Matt
    Pellenbarg, Jacqueline
    Raja, Haroon
    Matus, Ismael
    CHEST, 2020, 158 (04) : 1181A - 1181A
  • [4] Silver Nitrate-coated versus Standard Indwelling Pleural Catheter for Malignant Effusions The SWIFT Randomized Trial
    Shrager, Joseph B.
    Bhatnagar, Rahul
    Kearney, Christine T.
    Retzlaff, Nathan P.
    Cohen, Evan
    Stanton, Andrew E.
    Keyes, Colleen
    Wahidi, Momen M.
    Gillespie, Colin
    Rahman, Najib
    Kerry, Anthony L.
    Feller-Kopman, David
    Nader, Daniel
    Akulian, Jason
    Chen, Alex
    Berry, Mark
    Majid, Adnan
    Reddy, Chakravarthy
    Tremblay, Alain
    Maskell, Nick A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (10) : 1722 - 1729
  • [5] Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions
    Fortin, Marc
    Tremblay, Alain
    JOURNAL OF THORACIC DISEASE, 2015, 7 (06) : 1052 - 1057
  • [6] Ambulatory Thoracoscopic Pleurodesis Combined With Indwelling Pleural Catheter in Malignant Pleural Effusion
    Foo, Chuan T.
    Pulimood, Thomas
    Knolle, Martin
    Marciniak, Stefan J.
    Herre, Jurgen
    FRONTIERS IN SURGERY, 2021, 8
  • [7] The Seal-Mpe Trial: A Phase I Safety Evaluation Of A Novel Silver Nitrate Coated Indwelling Pleural Catheter
    Bhatnagar, R.
    Zahan-Evans, N.
    Kearney, C.
    Tremblay, A.
    Maskell, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] Use of a Drug Eluting Pleural Catheter for Pleurodesis in a Large Animal Model
    Tremblay, A.
    Stather, D. R.
    MacEachern, P.
    Dumitriu, S.
    Maxwell, L.
    Greene, C.
    Kelly, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [9] Predictors of Clinical Use of Pleurodesis and/or Indwelling Pleural Catheter Therapy for Malignant Pleural Effusion
    Fysh, Edward T. H.
    Bielsa, Silvia
    Budgeon, Charley A.
    Read, Catherine A.
    Porcel, Jose M.
    Maskell, Nick A.
    Lee, Y. C. Gary
    CHEST, 2015, 147 (06) : 1629 - 1634
  • [10] INDWELLING PLEURAL CATHETER OR TALC PLEURODESIS: WHICH SHOULD WE FAVOUR?
    Sheel, F. L.
    Akbar, S.
    Davies, H. E.
    THORAX, 2017, 72 : A105 - A105